biostudies-literatureUnknown66(4)Khawand C<h4>Objectives</h4>The primary objective was to assess the accuracy of prenatal examination in detecting and characterizing perinatal solid tumors of the thoracoabdominopelvic region. Secondary objectives were to describe the epidemiology, clinical characteristics and outcome of these tumors.<h4>Methods</h4>This was a retrospective multicenter study of all patients with a thoracic, abdominal or pelvic tumor diagnosed prenatally or within the first 3 months after birth in the Île-de-France area between January 2010 and May 2021. The gestational age at which a mass was detected on prenatal imaging, or the postnatal age at which the first tumor-related sign or symptom was noted, in addition to the timing of postnatal diagnostic confirmation (clinicoradiological or pathological), were extracteUltrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology499-508https://www.ebi.ac.uk/biostudies/studies/S-EPMC12488202biostudies-literaturePrenatal diagnosis and postnatal management of perinatal thoracoabdominopelvic tumors: multicenter experience.PMC12488202Sarnacki SQuibel TVille YVivanti AGrevent DBoutroux HOrbach DRosenblatt JMartinovic JBerrebi DMinard-Colin VBoudjemaa SGuimiot FMoalla SRoux NBrisse HJIrtan SPhilippe-Chomette PBranchereau SKhawand CLuton DMussini CJouannic JMCollaboratorsfalsePrenatal diagnosis and postnatal management of perinatal thoracoabdominopelvic tumors: multicenter experience.<h4>Objectives</h4>The primary objective was to assess the accuracy of prenatal examination in detecting and characterizing perinatal solid tumors of the thoracoabdominopelvic region. Secondary objectives were to describe the epidemiology, clinical characteristics and outcome of these tumors.<h4>Methods</h4>This was a retrospective multicenter study of all patients with a thoracic, abdominal or pelvic tumor diagnosed prenatally or within the first 3 months after birth in the Île-de-France area between January 2010 and May 2021. The gestational age at which a mass was detected on prenatal imaging, or the postnatal age at which the first tumor-related sign or symptom was noted, in addition to the timing of postnatal diagnostic confirmation (clinicoradiological or pathological), were extracte2025-01-01T00:00:00Z2025 Oct2026-06-04T00:38:29.229Z2026-05-03T03:13:12.925ZS-EPMC124882024084768110.1002/uog.70000